Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Gilad Oren
Relationship:   President/CEO, Director
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   333,395    

Indirect Shares

  1,800      
Direct Value   $0    

Indirect Value

  $0      
Total Shares   335,195      
Total Value   $0      


Aprea Therapeutics, Inc.
 $0 Aprea Therapeutics, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

      
       
     Stock price went down :
      
       
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Aprea Therapeutics, Inc. APRE President/CEO, Director 2024-10-23 333,395 2024-10-23 1,800    Premium*  
* Premium Members only  

Records found :    10         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
APRE Aprea Therapeutics, Inc. President, CEO   •       –      –    2022-07-28 4 A $0.00 $0 D/D 101,300 330,314 0 -
APRE Aprea Therapeutics, Inc. President, CEO   •       •      –    2022-08-23 4 A $0.00 $0 D/D 6,045,100 6,375,414 0 -
APRE Aprea Therapeutics, Inc. President, CEO   •       •      –    2023-03-09 4 A $0.00 $0 D/D 4,000 322,770 0 -
APRE Aprea Therapeutics, Inc. President, CEO   •       •      –    2024-03-13 4 B $7.29 $14,580 D/D 2,000 324,770 2.81 -
APRE Aprea Therapeutics, Inc. President, CEO   •       •      –    2024-03-28 4 A $0.00 $0 D/D 6,725 331,495 0 -
APRE Aprea Therapeutics, Inc. President/CEO   •       •      –    2024-10-10 4 B $2.54 $381 D/D 150 331,645 2.73 -
APRE Aprea Therapeutics, Inc. President/CEO   •       •      –    2024-10-14 4 B $2.59 $2,590 D/D 1,000 332,645 2.73 -
APRE Aprea Therapeutics, Inc. President/CEO   •       •      –    2024-10-15 4 B $2.90 $725 D/D 250 332,895 2.73 -
APRE Aprea Therapeutics, Inc. President/CEO   •       •      –    2024-10-23 4 B $3.92 $1,958 D/D 500 333,395 2.73 -
APRE Aprea Therapeutics, Inc. President   •       •      –    2022-05-16 3 IO $0.00 $0 D/D 0 229,014 -

  10  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed